Results 31 to 40 of about 20,870 (211)

The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients

Kaohsiung Journal of Medical Sciences, 2012
This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj   +1 more source

The value of PRL in predicting prolactinοma in hyperprolactinemic PCOS [PDF]

, 2018
Background To identify a serum prolactin (PRL) cut‐off value indicative of a PRL‐producing adenoma in women with Polycystic Ovarian Syndrome (PCOS) and hyperprolactinemia and characterize such patients.
Angelousi, Anna, Dimitriadis, Georgios K., Kaltsas, Gregory, Kyritsi, Eleni Magdalini, Mehta, Hiten, Mytilinaiou, Maria, Randeva, Harpal S., Shad, Amjad   +7 more
core   +1 more source

Infertility after long-acting paliperidone palmitate treatment: A case report (tur)

Klinik Psikiyatri Dergisi, 2020
Hyperprolactinemia is a common side effect of antipsychotic treatments. Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor.
Kerim Uğur, Sevler Yıldız
doaj   +1 more source

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? [PDF]

РМЖ. Мать и дитя, 2020
Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? A.A. Olina D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St.
A.A. Olina
doaj  

Medical treatment of prolactinomas. [PDF]

, 2011
Prolactinomas, the most prevalent type of neuroendocrine disease, account for approximately 40% of all pituitary adenomas. The most important clinical problems associated with prolactinomas are hypogonadism, infertility and hyposexuality.
A Barlier, A Beckers, A Chattopadhyay, A Ciccarelli, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Colao, A Di Sarno, A Di Sarno, A Klibanski, A Liuzzi, A Saveanu, A Wakil, A Zárate, AG Lania, AI McCormack, AM Colao, Annamaria Colao, AP Heaney, BM Biller, C Di Somma, C Ferrari, C Rasmussen, C Wang, CY Choong, D Cheung, D Dallabonzana, D McCall, DA De Luis, DA Sisam, DG Johnston, DG Johnston, E Delgrange, E Delgrange, E Delgrange, E Valassi, EJ Lee, F Andersohn, F Bogazzi, F Bogazzi, FF Casanueva, G Raverot, G Schettini, G Zada, GA Kaltsas, HE Turner, I Shimon, I Shimon, J Gorski, J Kharlip, J Schlechte, J Verhelst, J Webster, JC Williams, JJ Orrego, JK Devin, JM Wilson, JP Singh, JS Bevan, JW van't Verlaat, K Thapar, K Thapar, KJ Gräf, L Vilar, LB Nachtigall, LC Tan, LD George, LJ Hofland, M Biswas, M De Rosa, M De Rosa, M De Rosa, M Esteller, M Giusti, M Kars, M Kars, M Lafeber, M Muratori, M Ono, M Rocheville, M Steiger, MC Koppelman, MD Bronstein, ME Molitch, ML Vance, MP Gillam, MP Gillam, MS Huda, N Herring, OM Dekkers, P Fainstein Day, P Lancellotti, P Moriondo, PG Crosignani, PU Freda, R Homburg, R Schade, R Zanettini, RB Rothman, S Cannavò, S Ekeblad, S Karunakaran, S Mohammed, S Vallette, SG Ren, Silvia Savastano, SW Lamberts, SW Lamberts, T Mindermann, T Sabuncu, T Tan, V Goffin, VG Rasmussen, VQ Passos, W Winkelmann, WJ Jeffcoate, WS Maxson, Y Greenman   +131 more
core   +1 more source

Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats [PDF]

, 2014
Background/Aim. There is a lack of data on the effects of prolactin on calcium metabolism and bone turnover in hyperprolactinemia of various origins.
Pešić Milica, Radojković Danijela, Ristić Tatjana   +2 more
core   +1 more source

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study [PDF]

, 2004
To evaluate the cardiovascular risk of polycystic ovary syndrome (PCOS), we investigated lipid profile, metabolic pattern, and echocardiography in 30 young women with PCOS and 30 healthy age- and body mass index (BMI)-matched women. PCOS women had higher
CASCELLA, TERESA, COLAO, ANNAMARIA, F. Zullo, L. Tauchmanovà, LOMBARDI, GAETANO, ORIO, FRANCESCO, PALOMBA, STEFANO, SPINELLI, LETIZIA   +7 more
core   +1 more source

Depression, anxiety, sexual function and quality of life in women with hyperprolactinemia [PDF]

Revista Brasileira de Ginecologia e Obstetrícia
Objective: To evaluate anxiety, depression, sexual function and quality of life in women with hyperprolactinemia. Methods: Cross-sectional study with 80 women divided into two groups: 30 women with hyperprolactinemia (Study Group) followed and treated ...
Renan Massao Nakamura, Daniela Angerame Yela, Amanda Carvalho Santos, Beatriz Cipriano Ribas, Pedro Henrique Rosa e Silva, Bianca Netto Motta, Gabriela Pravatta Rezende, Cristina Laguna Benetti-Pinto   +7 more
doaj   +1 more source

Sexual Dysfunction as a Side Effect of Hyperprolactinemia in Methadone Maintenance Therapy [PDF]

, 2013
Although endocrine abnormalities are recognized in opiate users, very little is known about the range of hormones affected, their pathophysiology and their clinical relevance.
Spasovska Trajanovska, Aneta, Vujovic, Viktorija, Ignjatova, Liljana, Janikevik Ivanovska, Danijela, Chibishev, Andon   +4 more
core   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source